Solara Active Pharma share price zooms 16% on Q2 turnaround; H1 net up 103x
A quarterly results development with market-wide reach.
· Business Standard Mkts
Solara Active Pharma Sciences reported a consolidated net profit of ₹28.59 crore in Q2FY27 and ₹44.70 crore in H1FY27. It posted a loss of ₹9.29 crore in Q2FY26 and profit of ₹0.42 crore in H1FY26.
Key facts
- Period
- Q2FY27 and Q2FY26
The analysis
Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- Sector exposure: Pharma & Healthcare.
- The immediate tone of coverage reads negative.
In this story
Related coverage
Q2 Results Live: Tata Communications Profit Soars Over 86%; Tips Music Declares Dividend
UCO Bank Q2 Results: Profit Jumps 27% As NII Tops Rs 2,800 Crore; Asset Quality Improves
Anthropic Revenue Jumps To $16.8 Billion In Quarter Before IPO
Persistent Systems Q2: Net Profit Falls 27% Even As Revenue Sees A Rise
Wipro faces slow recovery as revenue and deal wins lag peers